Finance
How to unsubscribe on your Snapchat Discover page
If you’ve found yourself looking for an “unsubscribe” button for an account or publication you subscribed to on the Discover page on Snapchat, don’t worry: It’s not you, there is no such button within the app.
However, that doesn’t mean you can’t unsubscribe if you’re no longer interested in whatever that publication or account is creating. The steps you’d take to do so are ever so slightly less obvious than you might imagine.
That said, it should still only take you a minute or less to complete the unsubscribing process, assuming that account or publication regularly puts out content and you know your way around the app.
Here’s everything you need to know to get it done.
How to unsubscribe on Snapchat
Unsubscribing from an account or publication via Snapchat’s Discover page is extremely easy and can be quickly accomplished, provided you know your way around the app.
1. Open the Snapchat app and log into your account, if necessary.
2. Swipe across the screen from right to left to get the Stories page.
3. Scroll down, if necessary, to get to the “Subscriptions” section of the page.
4. Tap and hold down on a story from the account or publication you want to unsubscribe from.
5. Toggle off the “Subscribe” option to unsubscribe from that account or publication.
-
Business7 days ago
This camera trades pictures for AI poetry
-
Business6 days ago
TikTok Shop expands its secondhand luxury fashion offering to the UK
-
Business7 days ago
Boston Dynamics unveils a new robot, controversy over MKBHD, and layoffs at Tesla
-
Business5 days ago
Mood.camera is an iOS app that feels like using a retro analog camera
-
Business5 days ago
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
-
Business4 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Entertainment5 days ago
Furious Watcher fans are blasting it as ‘greedy’ over paid subscription service
-
Business3 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs